a) determination of the levels of sialidase by means of the procedure described in Cauci et al. Am J Obstet Gynecol 1998; 178; 511-5 and/or prolidase activity by means of the procedure described in Cauci et al. J Infect Dis 1998; 178; 1698-706 in samples of body fluid;b) determination of the pH value of said body fluid samples;c) selecting the samples having a sialidase value equal or above 5.0 nmol of methoxyphenol and/or a prolidase level equal or above 1500 mOD for prolidase and a pH ≥ 5.0.;Consequently, this method gives the physician an efficient tool to decide whether or not to administer a pharmacological therapy to women at risk of severe adverse outcomes."/> Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women
首页> 外国专利> Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women

Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women

机译:酶活和pH测试用于确定女性体液样本中的妇产科并发症风险

摘要

The current invention describes a method for selecting a particular population of women having a risk of developing obstetric or gynecologic pathologies indicated as odds ratio (OR) value higher than 5.5, comprising the following steps in order:a) determination of the levels of sialidase by means of the procedure described in Cauci et al. Am J Obstet Gynecol 1998; 178; 511-5 and/or prolidase activity by means of the procedure described in Cauci et al. J Infect Dis 1998; 178; 1698-706 in samples of body fluid;b) determination of the pH value of said body fluid samples;c) selecting the samples having a sialidase value equal or above 5.0 nmol of methoxyphenol and/or a prolidase level equal or above 1500 mOD for prolidase and a pH ≥ 5.0.;Consequently, this method gives the physician an efficient tool to decide whether or not to administer a pharmacological therapy to women at risk of severe adverse outcomes.
机译:本发明描述了一种选择特定人群的方法,该人群具有发展为妇产科或妇科病理学的风险,其优势比(OR)值高于5.5,依次包括以下步骤: a)通过Cauci等人的方法确定唾液酸酶的水平。 1998年Am Obstet Gynecol; 178;通过Cauci等人,J.Biol.215:403-10中所述的方法,使蛋白和/或脯氨酸酶的活性达到511-5。传染病杂志1998; 178; 1698-706在体液样品中; b)确定所述体液样品的pH值; c)选择唾液酸酶值等于或大于5.0 nmol的样品或大于或等于1500 mOD的脯氨酸蛋白酶和pH≥5.0的脯氨酸蛋白酶水平的测定。 ;因此,该方法为医师提供了一个有效的工具来决定是否进行药物治疗对有严重不良后果风险的妇女。

著录项

  • 公开/公告号EP1528396A1

    专利类型

  • 公开/公告日2005-05-04

    原文格式PDF

  • 申请/专利权人 UNIBIO S.R.L.;

    申请/专利号EP20040022918

  • 发明设计人 CAUCI SABINA;

    申请日2004-09-27

  • 分类号G01N33/569;G01N33/50;C12Q1/34;C12Q1/37;G01N33/48;

  • 国家 EP

  • 入库时间 2022-08-21 22:07:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号